Searched for
NEW DRUG PRICING POLICY
India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...- RBI MPC: Growth rate could top 7% if oil prices fall furtherThe MPC members had voted for a status quo in the June policy, citing resilient growth and the need to assess inflation impact while statin...
- Drugmakers yet to see gains from government's minimum import price policyGovernment's Minimum Import Price (MIP) initiative to boost domestic drug makers faces a slow start. Despite setting price thresholds for k...
- New policy formulated for evaluation of Private CBSE students in Gulf countries: Centre to Supreme CourtThe Supreme Court was informed by the Centre about a new CBSE policy for private students whose Class XII exams in Gulf countries were canc...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- Staggering amounts of fentanyl hit US streets as the DEA watched and took no action, records showDEA agents in New Mexico allegedly allowed hundreds of thousands of fentanyl pills onto streets between 2023-2025, prioritizing larger case...
- Newsmaker | Who is Abelardo De La Espriella, Colombia's new right-wing president?Colombia has elected nationalist lawyer Abelardo De La Espriella as its new president, signaling a significant political shift. Known as "T...
- Lower oil prices open door for MPC to time policy normalisation: ICICI ResearchFalling oil prices and easing geopolitical tensions have improved India's inflation outlook, giving the Monetary Policy Committee room to d...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- US probes Germany's drug pricing policies, opens door to tariffsThe US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US t...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- Who is Bobby Charles? Former Bush administration official holds lead to win Maine GOP governor primary after ranked-choice runoffBobby Charles has won Maine's Republican gubernatorial primary. He secured victory after ranked-choice voting runoffs. Charles is an attorn...
- US launches trade investigation into Germany over drug pricingAmerica has started a trade probe into Germany's plan to cut pharmaceutical spending. U.S. Trade Representative Jamieson Greer stated the i...
- API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...
- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
Load More
